No. |
薬物名(臨床試験情報から抽出) |
DrugBank |
KEGG DRUG * |
KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 |
Abacavir |
Abacavir |
D00891, D07057 |
- |
- |
3件: 135, 265, 325 |
2 |
Baricitinib |
Baricitinib |
D10308 |
2件: JAK1, JAK2 |
32件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
3 |
Emtricitabine |
Emtricitabine |
D01199 |
- |
- |
4件: 25, 93, 265, 325 |
4 |
Lamivudine |
Lamivudine |
D00353 |
- |
- |
6件: 26, 42, 46, 135, 265, 325 |
5 |
Ly3009104 |
- |
- |
- |
- |
4件: 46, 49, 50, 325 |
6 |
Reverse transcriptase inhibitors: zidovudine, lamivudine, abacavir |
Lamivudine, Zidovudine |
D00353, D00413 |
- |
- |
1件: 325 |
7 |
Tenofovir |
Tenofovir |
D06074 |
- |
- |
5件: 2, 25, 93, 265, 325 |
8 |
Tenofovir (tdf) and emtricitabine (ftc) |
Emtricitabine |
D01199 |
- |
- |
1件: 325 |
9 |
Zidovudine |
Zidovudine |
D00413 |
- |
- |
6件: 25, 26, 135, 265, 325, 331 |